Role of CCL2/MCP-1 in Islet Transplantation
- 1 August 2010
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 19 (8), 1031-1046
- https://doi.org/10.3727/096368910x514639
Abstract
High levels of donor-derived CCL2 have been associated with poor islet allograft outcome in patients with type 1 diabetes. The aim of our work was to determine whether CCL2 secreted by the islet has independent proinflammatory effects that influence engraftment and graft acceptance. Both in mice and humans CCL2 is significantly positively associated with other cytokines/chemokines, in particular with the highly released “proinflammatory” IL-6 and CXCL8 or CXCL1. Transplantation of CCL2-/- islets into syngenic recipients did not improve the transplant function. Transplantation of islets into CCL2-/- syngenic recipients led to a significant improvement of transplant function and partial abrogation of local hepatic inflammation. When evaluated in human islets CCL2 release was strongly related to the immediate local inflammatory response in the liver and impacted short-term human islet function dependently by the induced inflammatory response and independently by the immunosuppressive therapy. The data showed that islet CCL2 release is a sign of “inflamed” islets without having a direct role in graft failure. On the other hand, a causal effect for developing detrimental proinflammatory conditions after transplant was proved for recipient CCL2. Strategies to selectively decrease recipient, but not donor, CCL2 release may increase the success of islet transplantation.Keywords
This publication has 48 references indexed in Scilit:
- Transplant Estimated FunctionDiabetes Care, 2008
- Subendothelial Heparan Sulfate Proteoglycans Become Major L-Selectin and Monocyte Chemoattractant Protein-1 Ligands upon Renal Ischemia/ReperfusionThe American Journal of Pathology, 2007
- Relevance of Hyperglycemia on the Timing of Functional Loss of Allogeneic Islet Transplants: Implication for Mouse ModelTransplantation, 2007
- Role of Donor-Derived Monocyte Chemoattractant Protein-1 in Murine Islet TransplantationJournal of the American Society of Nephrology, 2005
- Antimonocyte Chemoattractant Protein-1 Gene Therapy Attenuates Graft VasculopathyArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- In vivo transfection of NF-κB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in ratsKidney International, 2004
- Adult porcine islets produce MCP-1 and recruit human monocytes in vitroXenotransplantation, 2004
- Differential expression of b-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allograftsClinical Nephrology, 2004
- Adenovirus Transduction Induces Expression of Multiple Chemokines and Chemokine Receptors in Murine β Cells and Pancreatic IsletsAmerican Journal of Transplantation, 2003
- Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3European Journal of Immunology, 1994